Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

BETA ☆ NSE

BETA DRUGS LIMITED · code 759842 · INE351Y01019 · Pharma & Healthcare · series EQ · Daily price history

1,764.20 -38.10 (-2.11%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
48

ISA Signal Score: Neutral

Hold or watch: no clear edge. Based on prices to 2026-11-19. Confidence 100%.

Trend50
Momentum34
52-week range45
Volume72
Risk42
Fundamentals56

Working for it

  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • More volume on up days than down days (accumulation)

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • 50-day average is falling
  • Down 25% in 3 months
  • Profit fell 2% year on year

Measured reference levels (not forecasts): 20-day low 1,720.50, 52-week high 2,668.30, typical daily move 88.63, two typical moves below price 1,586.94.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 18.6%, ROCE 19.0%, debt 0.60x equity
GrowthFastSales 20.2%, profit 13.2% a year over 4 years
ValuationFairP/E 43.1 vs sector median 42.8
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 8.5 points
RiskHighSwings 61% a year, fell up to 41% from a peak, beta 0.81

Smart Investor Tips: BETA

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Pullback within a long-term uptrend: holding above the 200-day average (Rs 1,737.17) while digesting gains below the 50-day average (Rs 1,931.38).
  • High capital efficiency: ROE of 18.6% indicates strong returns on shareholder equity.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Deep drawdown (-37.2% from 52-week high). Verify earnings trend and balance-sheet debt before treating a low price as a bargain.
  • High 30-day annualized volatility (76%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceBUY / POSITIVE IN ZONE (Score 81/100)

Strong technical, volume & cash-flow setup. Best support area: Rs 1,702.43 – Rs 1,764.20 (Ideal entry ~Rs 1,733.32). Stagger 50% near Rs 1,764.20 and 50% near Rs 1,702.43. Risk level / review below Rs 1,569.49; Swing Target Rs 2,099.60 (R:R 2.2x).

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 1,702.43 – Rs 1,764.20
Ideal ~Rs 1,733.32
Rs 1,764.20 Rs 1,702.43 Rs 1,569.49
ATR 5.0%
Rs 2,099.60 Rs 2,807.90 1 : 2.2
RSI 41 · Vol 1.54x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +45.1% · high 2,807.90 · low 1,171.10 · max drawdown -37.6%

Live Candlestick & TradingView Chart (BETA)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 19 Nov

P/E43.1sector median 42.8
P/B-price / book value
EPSRs 40.92grew 13.6% a year
Dividend yield-from saved dividend events
Debt to equity0.60xnet debt Rs 148 Cr
Sales growth20.2%a year over 4 years
Profit growth13.2%a year over 4 years
Operating margin19.5%net margin 10.7%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 3.27. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Adequate Debt & Cash Position · Score 71/100
Total Debt / Loans Rs 148 Cr Increased +Rs 10.0 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 148 Cr 29.8% of total assets
Debt to Equity & Interest Cover 0.60x D/E Interest cover: 4.6x EBIT
Operating Cash Flow (OCF) Rs 37.0 Cr OCF/PAT conversion: 90%
Free Cash Flow (FCF) - OCF minus Capex
  • Moderate Debt-to-Equity (0.60x).
  • High earnings quality: Operating Cash Flow converts 90% of net profit into real cash.

About BETA DRUGS

No company description saved yet. Use Profile below to read about this company.

Listed on NSE

Market capNot available
First listed24 Nov 2025NSE 24 Nov 2025
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 58.91% -0.19 pp, public 41.09%, as on 30 Sep 2026. Holder names and history

Day range1,732.20 to 1,808.60Open 1,790.40
52-week high2,807.90 -37.2% from high (12 Aug 2026)
52-week low990.10 +78.2% from low (25 Feb 2026)
Volume45,866 0.7x the 20-day average
RSI (14)43 neutral
Volatility (30d)76.2%annualised
990.10
2,807.90

Returns

1W-4.0%
1M+2.6%
3M-23.1%
6M+42.6%
1Y+6.5%
YTD+13.9%
3Y a year+13.4%
5Y a year+28.9%

Against the NIFTY 50

PeriodBETANIFTY 50Difference
1M+2.6%+11.5% -8.9 pts
3M-23.1%+5.3% -28.4 pts
6M+42.6%+7.9% +34.7 pts
1Y+6.5%-2.1% +8.5 pts

Risk over the past year

Volatility61%high
Deepest fall-40.9%from a peak
Beta0.81moves less than the index
Best day+20.0%12 Jun 2026
Worst day-17.7%16 Feb 2026
Up days47%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 6 / 9 · Solid Financial Health
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 10.7% × Asset Turnover: 0.77x × Equity Multiplier: 2.02x = ROE 18.6%
✓ Positive Net Profit (PAT > 0) Rs 41.0 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 37.0 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 90% conversion
⚠ Improving Return on Assets (ROA YoY) 8.3% vs 9.6%
✓ Conservative / Decreasing Debt-to-Equity 0.60x (prev 0.70x)
✓ Healthy Balance Sheet Asset Coverage 4.82x
✓ Institutional Return on Equity (ROE >= 14%) 18.6%
⚠ Stable / Expanding Profit Margin YoY 10.7% vs 11.6%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.77x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 88.094.010010387.094.0126137
Sales QoQ % -+6.8%+6.4%+3.0%-15.5%+8.0%+34.0%+8.7%
Operating Profit 18.017.020.021.016.018.027.031.0
Operating Margin (OPM %) 20.5%18.1%20.0%20.4%18.4%19.1%21.4%22.6%
Net Profit (PAT) 9.009.0012.012.09.009.0016.019.0
Profit QoQ % -+0.0%+33.3%+0.0%-25.0%+0.0%+77.8%+18.8%
Profit YoY % ----+0.0%+0.0%+33.3%+58.3%
Net Margin % 10.2%9.6%12.0%11.7%10.3%9.6%12.7%13.9%

Sales and profit Rs crore, consolidated

Sales growth+20.2%a year, 4Y
Profit growth+13.2%a year, 4Y
EPS growth+13.6%a year, 4Y
Avg ROE24.7%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales184227296362384
Sales growth-+23.4%+30.4%+22.3%+6.1%
Operating profit42.052.061.075.075.0
Operating margin22.8%22.9%20.6%20.7%19.5%
Other income1.001.001.002.0011.0
Interest2.002.003.007.0015.0
Depreciation7.0010.010.013.017.0
Profit before tax34.041.049.057.054.0
Tax rate28.0%25.0%25.0%26.0%24.0%
Net profit25.031.036.042.041.0
Profit growth-+24.0%+16.1%+16.7%-2.4%
Net margin13.6%13.7%12.2%11.6%10.7%
EPS (Rs)24.5830.4236.0842.0240.92

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)93.0123158197245
Borrowings21.020.015.0138148
Cash-----
Total assets158198254436496
Debt to equity0.23x0.16x0.09x0.70x0.60x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)30.023.031.036.037.0
Capital Expenditure (Capex)-----
Free Cash Flow (FCF = OCF - Capex)-----
OCF / Net Profit Conversion1.20x0.74x0.86x0.86x0.90x
Total Borrowings / Loans21.020.015.0138148
Cash & Bank Balances-----
Trade Receivables (Cr)-----
Receivable Days-----
Inventories (Cr)-----
Inventory Days-----

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE26.9%28.7%25.6%23.7%18.6%
ROCE31.9%33.6%33.0%25.2%19.0%
Interest cover18.00x21.50x17.33x9.14x4.60x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LTD 1,449.90 +0.4% - 17,769 37.7 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,084.60 -0.0% - 15,833 34.6 6.8 19.7% 27.0%
AARTIPHARMAARTI PHARMALABS LIMITED 1,024.60 +1.1% - 9,285 42.8 5.3 12.3% 11.7%
BLUEJETBLUE JET HEALTHCARE LTD 516.85 -0.3% - 8,965 54.8 10.6 19.4% 23.0%
AARTIDRUGSAARTI DRUGS LTD. 498.90 -1.4% - 4,587 26.9 3.6 13.4% 6.8%
DIVISLABDIVI S LABORATORIES LTD 11,178.00 +1.2% - - 115.6 - 15.3% 24.3%
WOCKPHARMAWOCKHARDT LIMITED 2,187.00 +7.9% - - - - - -
LAURUSLABSLAURUS LABS LIMITED 2,306.00 -0.7% - - - - - -
SUNPHARMASUN PHARMACEUTICAL IND L 1,900.00 +1.5% - - - - - -
MAXHEALTHMAX HEALTHCARE INS LTD 1,040.65 +1.7% - - - - - -
CIPLACIPLA LTD 1,418.50 +0.1% - - 29.5 - - 13.7%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L 8,738.00 -0.9% - - 64.7 - 21.1% 7.9%
Sector median- 42.86.813.4%

The 12 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 43: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 42% of days in the past year.

Support (prices below today's)

200-day average1,737.17-1.5%
20-day low1,616.00-8.4%
60-day low1,616.00-8.4%
52-week low990.10-43.9%

Resistance (prices above today's)

50-day average1,931.38+9.5%
20-day high2,099.60+19.0%
60-day high2,400.00+36.0%
52-week high2,807.90+59.2%

Zones buyers often watch

Lower quarter of the 1-year range 990.10 to 1,444.55 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 2,246.32 to 2,527.11 A common area for dips inside an uptrend.
Around the 200-day average 1,685.05 to 1,789.28 price is inside this zone now

Deepest fall from a peak in the past year: -40.9%. Currently -33.9% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average1,844.91 Price is 4.4% below
50-day average1,931.38 Price is 8.7% below
200-day average1,737.17 Price is 1.6% above
RSI (14)43Neutral
MACD (12, 26, 9)-36.80Above its signal line (momentum rising)
Volatility (30d)76.2%High yearly swings

Support and resistance

R21,844.73
R11,804.47
Pivot1,768.33
S11,728.07
S21,691.93

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 1,790.40 1,808.60 1,732.20 1,764.20 -2.11% 45,866
2026-11-18 1,792.50 1,841.50 1,765.80 1,802.30 +0.55% 16,700
2026-11-17 1,736.00 1,828.30 1,689.10 1,792.50 -1.30% 72,947
2026-11-16 1,830.70 1,858.00 1,771.20 1,816.20 -0.07% 17,094
2026-11-13 1,874.90 1,890.70 1,810.50 1,817.40 -1.15% 11,610
2026-11-12 1,891.40 1,891.80 1,806.10 1,838.50 -1.74% 15,840
2026-11-11 1,900.00 1,902.00 1,850.80 1,871.00 -0.56% 13,072
2026-11-09 1,834.10 1,925.90 1,820.60 1,881.60 +3.44% 22,889
2026-11-06 1,849.90 1,849.90 1,770.60 1,805.90 -1.89% 15,899
2026-11-05 1,817.40 1,847.00 1,800.20 1,840.70 +4.02% 19,489
2026-11-04 1,720.00 1,790.30 1,710.40 1,769.60 +2.85% 19,573
2026-11-03 1,796.50 1,845.90 1,695.10 1,720.50 -3.08% 24,491
2026-11-02 1,781.00 1,790.00 1,750.20 1,775.10 -1.30% 12,136
2026-10-30 1,880.60 1,880.60 1,790.60 1,798.40 -2.77% 23,660
2026-10-29 1,976.80 2,020.00 1,822.80 1,849.70 -6.43% 45,819
2026-10-28 1,955.00 2,099.60 1,903.80 1,976.80 +2.20% 70,040
2026-10-27 1,977.90 2,028.00 1,862.10 1,934.20 -2.21% 60,453
2026-10-26 1,896.00 2,035.00 1,895.20 1,977.90 +4.40% 75,889
2026-10-23 1,973.00 1,973.00 1,823.00 1,894.60 -3.88% 155,586
2026-10-22 1,664.70 1,997.60 1,616.00 1,971.00 +18.40% 567,442
2026-10-21 1,701.10 1,710.00 1,629.00 1,664.70 -3.19% 24,978
2026-10-19 1,779.80 1,779.80 1,700.00 1,719.60 -3.56% 18,555
2026-10-16 1,786.00 1,804.90 1,713.50 1,783.00 +1.87% 26,526
2026-10-15 1,700.00 1,870.00 1,674.20 1,750.30 +2.99% 161,207
2026-10-14 1,686.00 1,718.90 1,625.00 1,699.50 +1.30% 56,677
2026-10-13 1,845.00 1,859.40 1,660.00 1,677.70 -9.03% 125,336
2026-10-12 1,950.00 1,974.90 1,835.00 1,844.30 -5.43% 53,166
2026-10-09 1,910.00 1,974.00 1,703.10 1,950.20 +2.75% 158,957
2026-10-08 2,000.00 2,000.00 1,890.00 1,898.00 -4.69% 24,558
2026-10-07 1,980.00 2,024.00 1,980.00 1,991.40 -0.50% 9,114
2026-10-06 1,990.10 2,027.50 1,989.90 2,001.40 -0.13% 10,362
2026-10-05 2,064.50 2,173.80 1,986.70 2,004.00 -3.34% 19,642
2026-10-01 2,030.00 2,088.50 2,020.00 2,073.30 +0.99% 8,698
2026-09-30 2,079.90 2,095.00 2,026.60 2,053.00 -0.58% 7,218
2026-09-29 2,040.00 2,084.80 2,010.50 2,064.90 +1.21% 12,014
2026-09-28 2,080.00 2,100.00 2,020.00 2,040.30 -2.78% 12,981
2026-09-25 2,093.40 2,117.90 2,065.70 2,098.70 +0.25% 10,464
2026-09-24 2,190.50 2,197.90 2,080.00 2,093.40 -4.31% 16,148
2026-09-23 2,121.00 2,233.90 2,105.00 2,187.80 +3.93% 29,966
2026-09-22 2,080.00 2,170.00 2,063.40 2,105.00 +1.47% 20,315
2026-09-21 2,053.00 2,089.80 2,033.90 2,074.60 +0.94% 10,479
2026-09-18 2,095.20 2,147.90 2,025.00 2,055.20 -1.90% 14,462
2026-09-17 2,054.60 2,112.40 2,054.60 2,095.00 +1.46% 12,237
2026-09-16 2,082.20 2,094.70 2,002.60 2,064.90 -1.91% 13,984
2026-09-15 2,101.00 2,214.90 2,079.10 2,105.20 -0.63% 34,753
2026-09-11 2,070.00 2,147.80 2,013.80 2,118.50 +1.57% 18,068
2026-09-10 2,101.00 2,107.50 2,073.00 2,085.80 -1.03% 11,535
2026-09-09 2,150.50 2,163.90 2,105.00 2,107.60 -1.50% 9,360
2026-09-08 2,115.00 2,173.90 2,115.00 2,139.80 +0.75% 13,277
2026-09-07 2,204.00 2,204.00 2,087.90 2,123.90 -4.26% 42,831
2026-09-04 2,258.00 2,275.70 2,190.10 2,218.50 -1.79% 13,251
2026-09-03 2,145.00 2,285.00 2,145.00 2,258.90 +5.70% 27,003
2026-09-02 2,208.50 2,208.50 2,076.00 2,137.00 -3.16% 44,647
2026-09-01 2,277.00 2,277.00 2,180.00 2,206.80 -2.35% 12,964
2026-08-31 2,190.00 2,371.80 2,153.00 2,259.90 +2.68% 29,195
2026-08-28 2,194.20 2,253.00 2,166.20 2,201.00 +0.31% 16,090
2026-08-27 2,261.00 2,293.30 2,179.30 2,194.20 -2.95% 26,249
2026-08-26 2,370.00 2,387.00 2,255.00 2,261.00 -1.15% 18,297
2026-08-25 2,307.00 2,319.50 2,251.00 2,287.20 -0.86% 9,982
2026-08-24 2,300.10 2,400.00 2,289.10 2,307.00 -0.89% 20,970
2026-08-21 2,285.00 2,354.10 2,258.30 2,327.70 +1.42% 18,277
2026-08-20 2,446.00 2,446.00 2,270.00 2,295.00 -4.34% 34,219
2026-08-19 2,356.00 2,451.00 2,345.00 2,399.20 +1.88% 24,209
2026-08-18 2,435.00 2,519.90 2,326.20 2,355.00 -3.20% 51,810
2026-08-17 2,525.70 2,550.00 2,409.20 2,432.90 -4.62% 34,906
2026-08-14 2,600.00 2,600.00 2,473.00 2,550.70 -1.71% 14,886
2026-08-13 2,600.00 2,663.90 2,555.00 2,595.20 +1.41% 24,515
2026-08-12 2,721.00 2,807.90 2,544.10 2,559.00 -4.10% 110,912
2026-08-11 2,480.00 2,712.00 2,470.00 2,668.30 +6.56% 100,763
2026-08-10 2,366.00 2,579.80 2,366.00 2,504.00 +5.49% 65,018
2026-08-07 2,539.90 2,600.00 2,306.00 2,373.70 -5.76% 99,552
2026-08-06 2,400.00 2,550.00 2,398.90 2,518.90 +6.42% 66,076
2026-08-05 2,365.00 2,384.50 2,331.70 2,366.90 +0.08% 12,468
2026-08-04 2,370.00 2,390.00 2,302.10 2,365.00 +0.51% 16,520
2026-08-03 2,231.90 2,390.00 2,226.80 2,353.00 +5.43% 33,631
2026-07-31 2,192.20 2,341.90 2,184.00 2,231.90 +1.29% 25,918
2026-07-30 2,268.00 2,274.80 2,176.40 2,203.40 -1.33% 18,251
2026-07-29 2,145.00 2,243.90 2,109.00 2,233.20 +5.85% 34,121
2026-07-28 2,231.00 2,257.50 2,072.40 2,109.80 -5.42% 89,976
2026-07-27 2,365.00 2,365.00 2,225.60 2,230.70 -3.67% 29,565
2026-07-24 2,258.00 2,340.00 2,242.20 2,315.60 +1.69% 19,164
2026-07-23 2,335.00 2,399.00 2,250.00 2,277.20 -1.62% 25,376
2026-07-22 2,478.40 2,498.80 2,272.00 2,314.70 -6.61% 63,720
2026-07-21 2,437.00 2,495.40 2,383.90 2,478.40 +1.60% 51,162
2026-07-20 2,299.00 2,674.00 2,299.00 2,439.40 +9.43% 515,803
2026-07-17 2,280.00 2,389.00 2,206.80 2,229.10 -1.40% 42,504
2026-07-16 2,320.00 2,338.70 2,241.70 2,260.70 -1.92% 13,039
2026-07-15 2,354.70 2,362.70 2,277.10 2,305.00 -0.23% 18,575
2026-07-14 2,361.90 2,370.00 2,272.00 2,310.20 -1.60% 22,065
2026-07-13 2,370.00 2,424.30 2,322.10 2,347.80 -0.80% 48,772
2026-07-10 2,190.30 2,395.00 2,190.30 2,366.80 +8.06% 95,317
2026-07-09 2,008.50 2,239.40 2,008.50 2,190.30 +9.62% 88,056
2026-07-08 2,020.00 2,104.50 1,980.00 1,998.00 -3.44% 22,345
2026-07-07 2,148.00 2,153.40 2,052.30 2,069.10 -3.91% 15,448
2026-07-06 2,109.00 2,184.40 2,060.70 2,153.40 +3.01% 23,455
2026-07-03 2,165.20 2,205.00 2,076.70 2,090.50 -3.02% 36,025
2026-07-02 2,200.00 2,207.00 2,140.00 2,155.70 -1.34% 8,470
2026-07-01 2,195.60 2,227.90 2,108.50 2,185.00 +0.01% 18,332
2026-06-30 2,195.00 2,240.00 2,107.20 2,184.70 +1.00% 27,004
2026-06-29 2,099.90 2,244.80 2,099.90 2,163.10 +3.17% 40,825
2026-06-25 2,164.40 2,189.80 2,050.00 2,096.60 -3.13% 15,986
2026-06-24 2,093.20 2,215.00 2,093.20 2,164.40 +3.40% 31,114
2026-06-23 2,150.00 2,250.00 2,052.70 2,093.20 -2.53% 79,699
2026-06-22 2,200.00 2,250.00 2,125.10 2,147.50 +7.90% 122,538
2026-06-19 1,959.00 2,000.00 1,911.00 1,990.20 +2.15% 18,168
2026-06-18 1,891.90 2,031.00 1,891.90 1,948.30 +4.09% 61,620
2026-06-17 1,875.00 1,966.00 1,861.20 1,871.80 -0.98% 35,921
2026-06-16 1,870.00 1,915.00 1,850.00 1,890.30 +2.98% 67,489
2026-06-15 1,920.00 1,920.00 1,784.00 1,835.60 +3.64% 217,180
2026-06-12 1,525.00 1,771.20 1,525.00 1,771.20 +20.00% 180,651
2026-06-11 1,505.30 1,525.90 1,460.00 1,476.00 -1.82% 8,073
2026-06-10 1,540.00 1,550.00 1,490.00 1,503.30 -1.29% 9,557
2026-06-09 1,500.00 1,536.10 1,430.00 1,522.90 +6.49% 18,440
2026-06-08 1,455.90 1,492.70 1,404.60 1,430.10 -2.50% 7,678
2026-06-05 1,464.30 1,503.10 1,455.50 1,466.70 -0.34% 6,654
2026-06-04 1,461.20 1,506.40 1,438.60 1,471.70 +1.22% 8,973
2026-06-03 1,427.20 1,504.20 1,380.00 1,454.00 +2.68% 12,946
2026-06-02 1,399.00 1,429.90 1,399.00 1,416.10 -0.51% 13,810
2026-06-01 1,429.50 1,459.80 1,414.00 1,423.40 -0.43% 17,674
2026-05-29 1,450.00 1,450.00 1,410.10 1,429.50 -0.87% 23,766
2026-05-27 1,409.90 1,449.20 1,397.00 1,442.00 +2.99% 15,145
2026-05-26 1,382.30 1,451.00 1,382.30 1,400.20 +2.30% 26,753
2026-05-25 1,349.40 1,400.00 1,349.40 1,368.70 -0.58% 39,509
2026-05-22 1,247.00 1,420.00 1,230.00 1,376.70 +11.28% 82,141
2026-05-21 1,231.80 1,243.20 1,215.00 1,237.10 +1.82% 9,743
2026-05-20 1,204.50 1,284.70 1,192.20 1,215.00 +1.91% 21,154
2026-05-19 1,256.00 1,263.00 1,180.00 1,192.20 -1.97% 27,652
2026-05-18 1,250.00 1,275.10 1,171.10 1,216.20 -4.38% 34,327

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 14 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Beta Drugs Limited, ISIN INE351Y01019.

Promoters and group
58.91%
-0.19 pp vs Jun 2026
Foreign portfolio investors
1.37%
no previous quarter
Domestic institutions
6.45%
no previous quarter
Public (all, Category B)
41.09%
+0.19 pp vs Jun 2026
Resident individuals up to Rs 2 lakh
13.19%
no previous quarter

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group59.10%58.91%-0.19 pp--7.82 ppPromoter holding fell. A change alone is not a sell or buy signal. Check the filing for the reason (market sale, transfer inside the group, new issue).
Foreign portfolio investors-1.37%---New disclosure: not reported in the previous period.
Domestic institutions-6.45%---New disclosure: not reported in the previous period.
Public (all, Category B)40.90%41.09%+0.19 pp-+7.82 ppPublic holding rose. This is the mirror of promoter and other changes. It does not show what retail investors did.
Resident individuals up to Rs 2 lakh-13.19%---New disclosure: not reported in the previous period.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
Neeraj BatraIndividuals Or HUF64,73,63158.21% -
Suryavanshi Commotrade Private LimitedBodies Corporate6,80,0266.11% -
Ashish KacholiaResident Individual Shareholders Holding Nominal Share Capital In Excess Of Rs Two Lakh4,92,6814.43% -
Healthquad Trust IIAlternative Investment Funds4,76,3774.28% -
Inti Capital Vcc - Inti Capital IForeign Companies2,22,2752.00% -
Airavat Capital Trust - Airavat Capital Trust IIAlternative Investment Funds1,77,1711.59% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202658.91%-0.19 pp41.09%+0.19 pp14 Oct 2026
Jun 202659.10%0.00 pp40.90%0.00 pp17 Jul 2026
May 202659.10%-5.53 pp40.90%+5.53 pp11 Jun 2026
Mar 202664.63%-0.27 pp35.37%+0.27 pp06 Apr 2026
Dec 202564.90%-1.83 pp35.10%+1.83 pp13 Jan 2026
Sep 202566.73%0.00 pp33.27%0.00 pp13 Oct 2025
Jun 202566.73%0.00 pp33.27%0.00 pp09 Jul 2025
Mar 202566.73%-33.27%-08 Apr 2025NSE
Mar 202566.73%0.00 pp33.27%0.00 pp27 Mar 2025NSE
Dec 202466.73%0.00 pp33.27%0.00 pp14 Jan 2025NSE
Nov 202466.73%0.00 pp33.27%0.00 pp03 Dec 2024NSE
Sep 202466.73%0.00 pp33.27%0.00 pp12 Oct 2024NSE
Jun 2024 revised66.73%0.00 pp33.27%+0.02 pp19 Jul 2024NSE
Mar 202466.73%0.00 pp33.25%-0.01 pp15 Apr 2024NSE
Dec 2023 revised66.73%0.00 pp33.26%-0.01 pp08 Jan 2024NSE
Sep 2023 revised66.73%0.00 pp33.27%+0.01 pp09 Oct 2023NSE
Jun 202366.73%0.00 pp33.26%-0.01 pp11 Jul 2023NSE
Mar 202366.73%+0.02 pp33.27%-0.02 pp10 Apr 2023NSE
Dec 202266.71%0.00 pp33.29%0.00 pp09 Jan 2023NSE
Sep 202266.71%0.00 pp33.29%0.00 pp15 Oct 2022NSE
Jun 202266.71%0.00 pp33.29%0.00 pp16 Jul 2022NSE
Mar 202266.71%0.00 pp33.29%-0.01 pp08 Apr 2022NSE
Dec 202166.71%+0.03 pp33.30%-0.01 pp06 Jan 2022NSE
Sep 202166.68%-33.31%-11 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

2026

  • 19NovOther business mattersBoard meeting · NSE record

Events come from the exchange corporate action records. A fall or rise in price is never treated as a dividend, bonus or split.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.